Published in J Am Coll Cardiol on March 15, 1992
High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart (2003) 2.25
Diastolic Dyssynchrony in Acute ST Segment Elevation Myocardial Infarction and Relationship with Functional Recovery of Left Ventricle. J Cardiovasc Ultrasound (2016) 0.75
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med (2000) 13.25
Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med (1984) 3.81
Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation (1998) 3.68
Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med (1990) 3.12
Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet (2001) 3.02
Real-time radionuclide cineangiography in the noninvasive evaluation of global and regional left ventricular function at rest and during exercise in patients with coronary-artery disease. N Engl J Med (1977) 2.94
Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA (1997) 2.93
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med (1987) 2.88
Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation (1989) 2.56
An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program Working Group. Ann Emerg Med (1997) 2.27
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med (1987) 2.18
Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary. Circulation (2000) 2.07
Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Circulation (1991) 2.06
Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation (2000) 2.05
Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation (2001) 2.03
Impaired left ventricular diastolic filling in patients with coronary artery disease: assessment with radionuclide angiography. Circulation (1981) 2.00
Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation (1993) 1.90
Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (1993) 1.89
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation (1985) 1.81
Quantitative imaging of iodine-124 with PET. J Nucl Med (1996) 1.69
Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart (2005) 1.65
Noninvasive assessment of left ventricular diastolic function: comparative analysis of Doppler echocardiographic and radionuclide angiographic techniques. J Am Coll Cardiol (1986) 1.59
Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol (1987) 1.57
[18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability? Circulation (1998) 1.54
Exercise-induced ischemia in mildly symptomatic patients with coronary-artery disease and preserved left ventricular function. Identification of subgroups at risk of death during medical therapy. N Engl J Med (1984) 1.51
Improvement in hypertension in patients with diabetes mellitus after kidney/pancreas transplantation. Circulation (2001) 1.50
Sudden cardiac death without warning. Possible mechanisms and implications for screening asymptomatic populations. N Engl J Med (1989) 1.50
An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: executive summary of a National Heart Attack Alert Program Working Group Report. Ann Emerg Med (1997) 1.50
Improvement of the age-related impairment in left ventricular diastolic filling with verapamil in the normal human heart. Circulation (1994) 1.46
Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (1987) 1.46
Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris. Am J Cardiol (1981) 1.45
Natural history of left ventricular function during 1 year after acute myocardial infarction: comparison with clinical, electrocardiographic and biochemical determinations. Am J Cardiol (1980) 1.42
The effect of coronary artery bypass grafting on left ventricular systolic function at rest: evidence for preoperative subclinical myocardial ischemia. Am J Cardiol (1988) 1.42
Angiogenic effects of low molecular weight heparin in patients with stable coronary artery disease: a pilot study. J Am Coll Cardiol (1993) 1.42
Regional thallium uptake in irreversible defects. Magnitude of change in thallium activity after reinjection distinguishes viable from nonviable myocardium. Circulation (1992) 1.40
Sensitivity, specificity and predictive accuracy of radionuclide cineangiography during exercise in patients with coronary artery disease. Comparison with exercise electrocardiography. Circulation (1979) 1.40
A theoretical comparison of first-pass and gated equilibrium methods in the measurement of systolic left ventricular function. J Nucl Med (1991) 1.39
Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med (1988) 1.31
Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy. Circulation (1981) 1.30
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol (1996) 1.27
Identification of viable myocardium. Circulation (1996) 1.24
Observations on the optimum time for operative intervention for aortic regurgitation. I. Evaluation of the results of aortic valve replacement in symptomatic patients. Circulation (1980) 1.22
Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries, and abnormal vasodilator reserve. Circulation (1985) 1.21
Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am Heart J (2001) 1.20
Effects of coronary-artery bypass on global and regional left ventricular function during exercise. N Engl J Med (1978) 1.18
AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol (2001) 1.17
Exercise-induced left ventricular dysfunction in symptomatic and asymptomatic patients with aortic regurgitation: assessment with radionuclide cineangiography. Am J Cardiol (1978) 1.17
Hemodynamic and clinical effects of combined verapamil and propranolol therapy in angina pectoris. Am J Cardiol (1982) 1.14
Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol (1999) 1.13
Technetium-99m isonitrile myocardial uptake at rest. II. Relation to clinical markers of potential viability. J Am Coll Cardiol (1989) 1.10
Observations on the optimum time for operative intervention for aortic regurgitation. II. Serial echocardiographic evaluation of asymptomatic patients. Circulation (1980) 1.10
Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation (1987) 1.09
Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil. Am J Cardiol (1983) 1.07
Noise reduction in oncology FDG PET images by iterative reconstruction: a quantitative assessment. J Nucl Med (2001) 1.07
Ejection fraction by count rate from gated images. J Nucl Med (1978) 1.07
Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation (1991) 1.06
Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. Circulation (1985) 1.06
Relative lymphocyte count: a prognostic indicator of mortality in elderly patients with congestive heart failure. Am Heart J (2001) 1.05
Thallium 201 for assessment of myocardial viability. Semin Nucl Med (1991) 1.04
Reversal of left ventricular dysfunction after aortic valve replacement for chronic aortic regurgitation: influence of duration of preoperative left ventricular dysfunction. Circulation (1984) 1.04
Improved myocardial function during exercise after successful percutaneous transluminal coronary angioplasty. N Engl J Med (1982) 1.04
Noise characteristics of 3-D and 2-D PET images. IEEE Trans Med Imaging (1998) 1.03
ECG-gated scintillation probe measurement of left ventricular function. J Nucl Med (1977) 1.03
Aortic valve replacement without myocardial revascularization in patients with combined aortic valvular and coronary artery disease. Circulation (1981) 1.03
Investigation of the mechanism of chest pain in patients with angiographically normal coronary arteries using transesophageal dobutamine stress echocardiography. J Am Coll Cardiol (1997) 1.02
Regional left ventricular wall thickening. Relation to regional uptake of 18fluorodeoxyglucose and 201Tl in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation (1992) 1.02
Survival and functional results after valve replacement for aortic regurgitation from 1976 to 1983: impact of preoperative left ventricular function. Circulation (1985) 1.02
Late cardiac effects of therapeutic mediastinal irradiation. Assessment by echocardiography and radionuclide angiography. N Engl J Med (1983) 1.01
Cardiorespiratory effects of immunotherapy with interleukin-2. J Clin Oncol (1989) 1.01
Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease. Circulation (2000) 1.00
Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration. Am J Cardiol (1981) 0.99
Relation between thallium uptake and contractile response to dobutamine. Implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation (1995) 0.97
Doxorubicin cardiotoxicity: assessment of late left ventricular dysfunction by radionuclide cineangiography. Ann Intern Med (1981) 0.97
A "hybrid" method for measuring myocardial wall thickening from gated PET/SPECT images. J Nucl Med (1997) 0.97